China National Medicines Corp Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - China National Medicines Corp Ltd

Watchlist Manager

Watchlist

Price: 26.25 CNY -0.61% Market Closed

Market Cap: ¥19.8B

C	China National Medicines Corp Ltd SSE:600511	CN
	Nel ASA F:D7GA	NO
	Insulet Corp NASDAQ:PODD	US
E	Eugene Special Purpose Acquisition 8 Co KOSDAQ:413630	KR
O	Obsidian Energy Ltd AMEX:OBE	CA
	Shaftesbury Capital PLC LSE:SHC	UK
E	Eni SpA DUS:ENI	IT
	Indra Sistemas SA MAD:IDR	ES
	Fastly Inc NASDAQ:FSLY	US
C	Costar Group Inc XMUN:RLG	US
F	Fortive Corp SWB:F03	US
	Saga Pure ASA OSE:SAGA	NO
	APA Group ASX:APA	AU
S	Spyrosoft SA WSE:SPR	PL
	Artificial Intelligence Technology Solutions Inc OTC:AITX	US

Profitability Summary

China National Medicines Corp Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Declining Gross Margin

8% > 6%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

5% > 4%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

4% > 4%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

4% > 2%

Positive ROE

11%

Positive 3Y Average ROE

Positive 3Y Average ROIC

13%

Declining ROIC

15% > 9%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.